The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

Biochemistry, Genetics and Molecular Biology

• Nested Gene 100%
• Pharmacogenomics 100%
• Methotrexate 100%
• Pediatrics 66%
• Mercaptopurine 66%
• Life 33%
• Hydrolase 33%
• Organic Anion Transporter 33%
• Dihydrofolate Reductase 33%
• Triphosphatase 33%
• Solute 33%
• Inosine 33%
• SLC19A1 33%
• SLCO1B1 33%
• Solute Carrier Family 33%
• Thiopurine Methyltransferase 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Toxicity 100%
• Acute Lymphoblastic Leukemia 100%
• Methotrexate 37%
• Drug 25%
• Mercaptopurine 25%
• Chemotherapy 12%
• Dihydrofolate Reductase 12%
• Bone Marrow Suppression 12%
• Thymidylate Synthase 12%
• Gastrointestinal Toxicity 12%
• Inosine 12%
• Reduced Folate Carrier 12%
• Nudix Hydrolase 12%
• SLCO1B1 12%
• Thiopurine Methyltransferase 12%
• Solute Carrier Organic Anion Transporter 1B1 12%